The medication deliberately slows the rate at which food moves from the stomach into the small intestine to regulate blood glucose levels
Ongoing Safety Evaluation The FDA Roles: The FDAs responsibilities go beyond just approving drugs initially
Its common adverse reactions are similar to other GLP-1 drugs, primarily consisting of gastrointestinal issues (nausea, diarrhea, vomiting, etc.), which are mostly mild to moderate and typically decrease over time
In March of last year, the French National Agency for the Safety of Medicines and the public insurer the Assurance Maladie posted an an alert stating that Ozempic would be subject to enhanced surveillance. According to Le Monde , Isabelle Yoldjian, director of drugs in oncology, cardiology and endocrinology at FNASM, said that given the shortage situation, any use of Ozempic by people who do not need it risks depriving patients of their treatment. Despite widespread scarcity, U.S
What if I miss a dose
